Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Molecular Therapy. Methods & Clinical Development
|
September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease
Paul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Cell Reports
|
May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Caroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 20, 2019
Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements
Richard A Morgan, Mildred J Unti, Bamidele Aleshe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Blood Advances
|
April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease
Chattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Journal for Immunotherapy of Cancer
|
August 2, 2020
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141<sup>+</sup> dendritic cells to activate naïve and memory NY-ESO-1-specific CD8<sup>+</sup> T cells
Kelly-Anne Masterman, Oscar L Haigh, Kirsteen M Tullett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 11, 2019
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero, Anastasia Lomova, Suzanne Said, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 22, 2013
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency
Denise A Carbonaro, Lin Zhang, Xiangyang Jin, et al.
The Journal of Clinical Investigation
|
July 19, 2013
β-globin gene transfer to human bone marrow for sickle cell disease
Zulema Romero, Fabrizia Urbinati, Sabine Geiger, et al.
Blood
|
March 4, 2015
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D Hoban, Gregory J Cost, Matthew C Mendel, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Molecular Therapy. Methods & Clinical Development
|
September 23, 2024
Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease
Paul G Ayoub, Julia Gensheimer, Lindsay Lathrop, et al.
Cell Reports
|
May 31, 2018
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Caroline Y Kuo, Joseph D Long, Beatriz Campo-Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 20, 2019
Improved Titer and Gene Transfer by Lentiviral Vectors Using Novel, Small β-Globin Locus Control Region Elements
Richard A Morgan, Mildred J Unti, Bamidele Aleshe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 14, 2016
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D Hoban, Dianne Lumaquin, Caroline Y Kuo, et al.
Blood Advances
|
April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell Disease
Chattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Journal for Immunotherapy of Cancer
|
August 2, 2020
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141<sup>+</sup> dendritic cells to activate naïve and memory NY-ESO-1-specific CD8<sup>+</sup> T cells
Kelly-Anne Masterman, Oscar L Haigh, Kirsteen M Tullett, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 11, 2019
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero, Anastasia Lomova, Suzanne Said, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 22, 2013
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency
Denise A Carbonaro, Lin Zhang, Xiangyang Jin, et al.
The Journal of Clinical Investigation
|
July 19, 2013
β-globin gene transfer to human bone marrow for sickle cell disease
Zulema Romero, Fabrizia Urbinati, Sabine Geiger, et al.
Blood
|
March 4, 2015
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D Hoban, Gregory J Cost, Matthew C Mendel, et al.
Page
of 5